Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
2500 participants
OBSERVATIONAL
2019-01-07
2038-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Biomarker Guided Antibiotic Treatment in Community-Acquired Pneumonia
NCT03146182
Community-Acquired Pneumonia - Study on the Initial Treatment With Antibiotics of Lower Respiratory Tract Infections
NCT01660204
Community-acquired Pneumonia in Buskerud County in Norway
NCT01563315
Clinical Characteristics and Outcome of Patients With Community Acquired Pneumonia
NCT06716099
Clinical Characteristics of Acutely Hospitalized Adults With Community-acquired- Pneumonia
NCT04681963
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Community-acquired pneumonia
Adults over 18 years old admitted with confirmed community-acquired pneumonia.
No intervention
Obervational
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention
Obervational
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Fever (temperature, ≥38.0°C)
* Hypothermia (\<35.0°C),
* New cough with or without sputum production
* Pleuritic chest pain
* Dyspnea
* Altered breath sounds on auscultation.
Exclusion Criteria
* Patients unwilling to give informed consent
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nordsjaellands Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Birgitte Lindegaard Madsen
Associated professor, MD, PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Birgitte Lindegaard, Assoc. Prof
Role: PRINCIPAL_INVESTIGATOR
Nordsjaellands Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Pulmonary and Infectious Diseases, Nordsjællands Hospital
Hillerød, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Ryrso CK, Hegelund MH, Dungu AM, Faurholt-Jepsen D, Pedersen BK, Ritz C, Krogh-Madsen R, Lindegaard B. Association between Barthel Index, Grip Strength, and Physical Activity Level at Admission and Prognosis in Community-Acquired Pneumonia: A Prospective Cohort Study. J Clin Med. 2022 Oct 27;11(21):6326. doi: 10.3390/jcm11216326.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Surviving Pneumonia
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.